Jeffrey J. Brown - Feb 3, 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Feb 3, 2023
Transactions value $
$67,608
Form type
4
Date filed
2/9/2023, 08:06 PM
Previous filing
Jan 12, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $1.29K +11.2 +0.47% $114.97 2.38K Feb 7, 2023 Direct F1
transaction MED Common Stock Purchase $59.9K +516 +1.41% $116.11 37K Feb 3, 2023 By Brown Equity Partners, LLC F2, F3
transaction MED Common Stock Purchase $6.46K +55.7 +1.41% $116.11 4K Feb 3, 2023 Jeffrey Brown Living Trust F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
F2 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F3 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member.
F4 The shares were acquired by the Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F5 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.